Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Cardiology | Internal Medicine | Critical Care | Nursing | Pulmonology | Journal

Back to Journal Articles

Pain Requires Meticulous Attention in Intensive Care Units

Last Updated: April 13, 2009.

 

Two reviews address the challenges of evaluating and managing pain in critically ill patients

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
In intensive care units, the evaluation and management of pain is a significant clinical challenge, according to two Contemporary Reviews in Critical Care Medicine published in the April issue of the journal Chest.

MONDAY, April 13 (HealthDay News) -- In intensive care units, the evaluation and management of pain is a significant clinical challenge, according to two Contemporary Reviews in Critical Care Medicine published in the April issue of the journal Chest.

In the first review, Kathleen Puntillo, of the University of California San Francisco, and colleagues address the evaluation of pain in intensive care unit (ICU) patients. They point out that only two pain behavior instruments -- the pain behavior scale and the Critical-Care Pain Observation Tool -- have been rigorously tested for use in ICUs. But they also discuss other less-validated tools such as the pain assessment, intervention, and notation (PAIN) algorithm, and a pain behaviors checklist. They write that when established tools for evaluating pain are insufficient, alternative methods should be considered.

In a second review, Brian L. Erstad, of the University of Arizona College of Pharmacy in Tucson, and colleagues address the management of pain in critically ill ICU patients. They point out that opioids have been the mainstay of pain control. They also discuss other medications that have been proposed as alternatives or adjuncts to opioids as well as non-pharmacologic, complementary therapies. But they emphasize that neither of these approaches has been well-studied in the ICU setting.

"Due to the paucity of high-level evidence on which to base pharmacologic treatment decisions, regimens must be based on known physiochemical, pharmacokinetic and pharmacodynamic characteristics of the agents in conjunction with extrapolations of evidence from other patient populations and settings," Erstad and colleagues write.

Several authors from the studies have ties to various pharmaceutical companies.

Abstract - Puntillo
Full Text
Abstract - Erstad
Full Text

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Drugs Effective in Treating Advanced Prostate Cancer Next: New Test May Predict Risk of End-Stage Renal Disease

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.